Commercial success of first peanut allergy treatment is not assured - STAT

Commercial success of first peanut allergy treatment is not assured - STAT

STAT Plus: FDA approves the first treatment for peanut allergy, but commercial success is hardly assured

By ADAM FEUERSTEIN

PATRICK SISON/AP

Aimmune believes Palforzia could deliver annual sales exceeding $1 billion and address a need for families dealing with life-threatening peanut allergy.

READ MORE